A phase II study of a 21 day continuous
A phase II study of a 21 day continuous infusion schedule with epirubicin in advanced gastric cancer
✍
De Vries, Elisabeth G.E.; Nanninga, Afien G.; Greidanus, Janke; Oremus, Evrard T
📂
Article
📅
1989
🏛
Elsevier Science
⚖ 162 KB